Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.99 | 17.25 |
| PEG Ratio (TTM) | 1.66 | -32.98 |
| P/S Ratio (TTM) | 2.57 | 5.16 |
| P/B Ratio (TTM) | 0.90 | 4.45 |
| P/FCF Ratio (TTM) | 21.77 | 14.74 |
| Price to 5YR AVG Earnings Ratio | -448.36 | 24.72 |
| Price to 5YR AVG FCF Ratio | 41.81 | 17.78 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.49% | 4.00% |
| ROE (TTM) | 3.05% | 27.24% |
| Net Profit Margin (TTM) | 8.56% | -9.14% |
| ROIC 5YR AVG | 16.40% | 12.12% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.01% | -54.20% | -21.69% |
| Revenue | 3.17% | -5.45% | -0.89% |
| Net Income | 35.34% | -54.29% | -21.50% |
| Cash Flow | 108.21% | -181.99% | -21.80% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.61 | 2.50 |
| Quick Ratio (TTM) | 2.93 | 1.87 |
| D/E Ratio (TTM) | N/A | -0.07 |
| Interest Coverage (TTM) | N/A | 16.82 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 3.57 | 4.38 |
| LTL to 5YR AVG FCF | N/A | 3.92 |
| Shares Outstanding Growth 5YR AVG | -0.73% | 25.21% |